Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00456157 | A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee | PHASE1 | COMPLETED | 33 | — | — | Mar 1, 2007 | Nov 1, 2008 | Jun 17, 2010 | 3 | United States |
| Name | Type | Description |
|---|---|---|
| Intra-articular Injection of OP-1 to affected knee | DRUG | - |
Inclusion Criteria: * Ambulatory subjects with OA of the knee with symptoms for at least 6 months and pain on the majority of days in the last 30 days. Symptoms must include knee joint pain, and may include crepitus, swelling and/or effusion of the knee. In subjects with bilateral knee OA, the more...